Watch for impulse-control dysregulation with dopamine agonists

In a large longitudinal study of 411 patients with early Parkinson’s disease, 356 (86.6%) were treated with a dopamine agonist at least once since the onset of their illness. In 306 patients who were known to have no evidence of an impulse control disorder (ICD...

Indomitable nature – the germs fight back.

Evolutionary biology can be irresistible, but also frightening. Evidence is now emerging that some bacterial strains are developing resistance to ethanol-based handwash, a phenomenon that has been suggested as an underlying contributor to the spread of VRE in...

Tianeptine – emerging as a public health risk

Tianeptine is an antidepressant drug available in over 60 countries worldwide.  The Australian TGA has recently become aware that tianeptine has been offered for sale under product name Stablon on at least one Australian website in powder form, and thus a submission...